Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study Evaluating the Efficacy of Certolizumab Pegol for Interstitial Cystitis

NCT02497976 is registered in ClinicalTrials.gov with ICStudy, LLC as lead sponsor.

NCT NCT02497976
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02497976 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study Evaluating the Efficacy of Certolizumab Pegol for Interstitial Cystitis
Lead sponsor
ICStudy, LLC
Phase
Phase 3
Overall status
Completed
Start date
December 15, 2015
Completion date
July 12, 2017
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cystitis, interstitial